EULAR recommendations for the management of large vessel vasculitis.

EULAR recommendations for the management of large vessel vasculitis.

OBJECTIVES: To develop European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis. METHODS: An expert group (10 rheumatologists, 3 nephrologists, 2 immunolgists, 2 internists representing 8 European countries and the USA, a clinical epidemiologist and a...

Bibliográfalaš dieđut
Váldodahkkit:	Mukhtyar, C, Guillevin, L, Cid, M, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C, Merkel, P, Raspe, H, Salvarani, C, Scott, D, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2009

Geahča maid

EULAR recommendations for the management of primary small and medium vessel vasculitis.
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2009)

Eular recommendations for vasculitis
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2007)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
Dahkki: Hellmich, B, et al.
Almmustuhtton: (2007)

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Dahkki: Yates, M, et al.
Almmustuhtton: (2016)

EULAR/ERA-EDTA RECOMMENDATIONS FOR THE MANAGEMENT OF ANCA-ASSOCIATED VASCULITIS
Dahkki: Yates, M, et al.
Almmustuhtton: (2016)

OP0053 Eular/ERA-EDTA Recommendations for The Management of Anca-Associated Vasculitis
Dahkki: Yates, M, et al.
Almmustuhtton: (2016)

Current evidence of factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis. A systematic review for the EULAR systemic vasculitis task force
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2007)

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts
Dahkki: Yates, M, et al.
Almmustuhtton: (2017)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2008)

EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis.
Dahkki: Basu, N, et al.
Almmustuhtton: (2010)

EULAR recommendations for conducting clinical studies and/or clinical trials in ANCA-associated vasculitis
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2007)

Eular recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis
Dahkki: Hellmich, B, et al.
Almmustuhtton: (2006)

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2011)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2006)

Factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2007)

Outpatient assessment of systemic vasculitis.
Dahkki: Nataraja, A, et al.
Almmustuhtton: (2007)

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).
Dahkki: Craven, A, et al.
Almmustuhtton: (2013)

Cardiovascular outcomes in ANCA associated vasculitis
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2008)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2008)

Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2008)

The future of damage assessment in vasculitis.
Dahkki: Seo, P, et al.
Almmustuhtton: (2007)

Long-term patient survival in ANCA-associated vasculitis
Dahkki: Flossmann, O, et al.
Almmustuhtton: (2011)

Long-term patient survival in ANCA-associated vasculitis.
Dahkki: Flossmann, O, et al.
Almmustuhtton: (2011)

Comparison of disease activity measures for ANCA-associated vasculitis.
Dahkki: Merkel, P, et al.
Almmustuhtton: (2004)

The role of biologic therapies in the management of systemic vasculitis.
Dahkki: Chan, A, et al.
Almmustuhtton: (2006)

Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2007)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2011)

Long-term survival of ANCA-associated vasculitis
Dahkki: Flossmann, O, et al.
Almmustuhtton: (2009)

Cardiovascular involvement in primary systemic vasculitis.
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2009)

Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2010)

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index.
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2011)

Long-term patient survival in ANCA-associated vasculitis.
Dahkki: Flossmann, O, et al.
Almmustuhtton: (2011)

Using the Birmingham Vasculitis Activity Score (BVAS) for diagnosing vasculitis
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2009)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
Dahkki: Walsh, M, et al.
Almmustuhtton: (2011)

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1—treatment of granulomatosis with polyangiitis and microscopic polyangiitis
Dahkki: Sara Monti, et al.
Almmustuhtton: (2023-07-01)

MEASUREMENT OF DAMAGE IN SYSTEMIC VASCULITIS: A COMPARISON OF THE VASCULITIS DAMAGE INDEX (VDI) WITH THE COMBINED DAMAGE ASSESSMENT INDEX (CDA)
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2010)

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
Dahkki: Merkel, P, et al.
Almmustuhtton: (2009)

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2011)

USING THE BIRMINGHAM VASCULITIS ACTIVITY SCORE (VERSION 3) FOR DIAGNOSING VASCULITIS
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2009)

Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2007)